Indivior Pharmaceuticals Inc Financial Ratios — INDV.L Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Return on Common Equity (%)	- -	304.26	71.18	39.03	24.32	3.4	5.46	22.07	9.21	-10.19	14.18	-3.06	0.15	- -
Return on Assets (%)	- -	108.78	99.49	68.71	27.08	3.26	4.37	18.39	8.38	-9.3	12.19	-2.44	-7.31	0.13
Return on Capital (%)	- -	304.26	71.18	28.83	16.77	3.17	4.69	18.83	8.73	- -	- -	- -	- -	55.31
Return on Invested Capital (%)	- -	309.69	- -	299.05	79.65	15.88	26.02	92.76	29.64	- -	- -	- -	- -	50.37
Gross Margin (%)	93.54	92.98	91.45	91.48	90.43	89.89	90.48	87.26	82.17	85.01	83.94	83.24	84.08	80.56
EBITDA Margin (%)	69.54	66.02	57.15	50.4	34.12	14.08	17.66	31.44	22.68	-24.11	22.88	23.86	22.23	19.19
Operating Margin (%)	69.54	66.02	57.15	50.4	34.12	14.08	17.66	31.44	22.68	-24.11	22.88	23.86	22.23	19.19
Incremental Operating Margin (%)	- -	14.12	153.66	131.68	213.86	-447.73	125.71	-139.77	62.73	- -	234.03	30.91	14.58	-15.79
Pretax Margin (%)	69.54	66.02	57.15	50.31	28.11	9.26	12.53	27.66	22.93	-26.74	24.02	-9.88	-13.63	1.18
Profit Margin (%)	48.96	45.33	40.21	36.14	22.49	3.31	5.31	27.36	17.07	-22.87	25.92	-4.88	-11.8	0.17
Net Income to Common Margin (%)	48.96	45.33	40.21	36.14	22.49	3.31	5.31	27.36	17.07	-22.87	25.92	-4.88	-11.8	0.17
Effective Tax Rate (%)	29.59	31.33	29.64	28.16	20	64.29	57.66	1.08	25.56	- -	- -	- -	- -	78.57
Dvd Payout Ratio (%)	- -	- -	48.88	124.07	10.09	197.14	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	304.26	36.39	-9.39	21.87	-3.3	5.46	22.07	9.21	-10.19	14.18	-3.06	0.15	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Total Debt	- -	- -	- -	736	605	535	482	241	293	285	286	277	283	375
ST Debt	- -	- -	- -	17	34	101	5	4	9	12	11	11	12	28
LT Debt	- -	- -	- -	719	571	434	477	237	284	273	275	266	271	347
Total Debt/EBITDA	- -	- -	- -	1.31	1.75	3.59	2.5	0.76	1.65	-1.83	1.58	1.29	1.16	1.64
Net Debt/EBITDA	-0.01	-0.03	-0.01	0.72	0.4	-1.05	-1.97	-2.16	-4.62	4	-4.75	-2.48	-0.31	0.06
Total Debt/EBIT	- -	- -	- -	1.31	1.75	3.59	2.5	0.76	1.65	-1.83	1.58	1.29	1.16	1.64
Net Debt/EBIT	-0.01	-0.03	-0.01	0.72	0.4	-1.05	-1.97	-2.16	-4.62	4	-4.75	-2.48	-0.31	0.06
EBITDA to Interest Expense	- -	- -	- -	562	6.65	3.39	5.22	11.29	8.09	-6.5	6.96	7.96	6.94	5.56
EBITDA-CapEx/Interest Expense	- -	- -	- -	536	6.06	2.59	4.05	9.82	7.77	-6.67	5.65	7.78	5.43	4.8
EBIT to Interest Expense	- -	- -	- -	562	6.65	3.39	5.22	11.29	8.09	-6.5	6.96	7.96	6.94	5.56
Interest Expense	- -	- -	- -	1	52	44	37	28	22	24	26	27	35	41
Common Equity/Total Assets	45.44	26.03	288.5	111.91	110.89	84.53	76.45	89.72	92.13	90.4	82.31	77.5	-12.9	-29.72
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	359.09	135.89	332.93	135.47	521.57	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	45.74	34.73	27.87	30.08	14.55	15.65	16.36	15.33	16.14	483.93	-2,041.18
Long-Term Debt/Total Assets (%)	- -	- -	- -	96.25	60.94	35.9	33.03	15.32	17.19	17.83	15.01	15.04	15.4	26.31
Total Debt/Equity (%)	- -	- -	- -	-154.95	-216.85	-181.36	-237.44	365.15	140.19	347.56	140.89	543.14	-147.4	-107.76
Total Debt/Capital (%)	- -	- -	- -	46.82	36.8	34.36	30.39	14.79	16.14	17.08	15.94	16.81	505.36	-2,205.88
Total Debt/Total Assets (%)	- -	- -	- -	98.53	64.57	44.25	33.38	15.58	17.74	18.62	15.61	15.66	16.08	28.43
Net Debt to Equity	-2.76	-17.24	10.61	-85.26	-49.46	53.22	187.68	-1,034.85	-393.78	-760.98	-423.65	-1,047.06	39.58	-4.02
Net Debt/Capital (%)	-2.83	-20.83	-0.57	32.63	11.72	-18.15	-52.7	-96.88	-109.01	-76.94	-124.28	-61.1	29.23	-4.17
EBITDA	872	884	695	562	346	149	193	316	178	-156	181	215	243	228
EBITDA-CapEx	847	881	692	536	315	114	150	275	171	-160	147	210	190	197
Operating Income (Loss)	872	884	695	562	346	149	193	316	178	-156	181	215	243	228

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Cash Ratio	0.02	0.06	0.02	0.72	0.77	0.67	1.01	1.13	1.43	1.43	1.37	0.88	0.32	0.34
Current Ratio	1.08	0.88	0.51	1.22	1.2	0.96	1.43	1.62	1.83	1.98	1.8	1.24	0.98	0.89
Quick Ratio	0.02	0.06	0.02	0.72	0.77	0.67	1.01	1.13	1.43	1.43	1.37	0.88	0.32	0.34
CFO/Avg Current Liab	- -	2.47	1.87	0.96	0.6	0.5	0.31	0.36	0.19	-0.29	0.5	- -	-0.26	0.03
Common Equity/Total Assets	45.44	26.03	288.5	111.91	110.89	84.53	76.45	89.72	92.13	90.4	82.31	77.5	-12.9	-29.72
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	359.09	135.89	332.93	135.47	521.57	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	45.74	34.73	27.87	30.08	14.55	15.65	16.36	15.33	16.14	483.93	-2,041.18
Long-Term Debt/Total Assets (%)	- -	- -	- -	96.25	60.94	35.9	33.03	15.32	17.19	17.83	15.01	15.04	15.4	26.31
Total Debt/Equity (%)	- -	- -	- -	-154.95	-216.85	-181.36	-237.44	365.15	140.19	347.56	140.89	543.14	-147.4	-107.76
Total Debt/Capital (%)	- -	- -	- -	46.82	36.8	34.36	30.39	14.79	16.14	17.08	15.94	16.81	505.36	-2,205.88
Total Debt/Total Assets (%)	- -	- -	- -	98.53	64.57	44.25	33.38	15.58	17.74	18.62	15.61	15.66	16.08	28.43
CFO/Total Liabilities	234.43	210.19	160.77	36.01	26.32	27.06	17.91	20.46	10.46	-13.32	21.67	-0.23	-15.37	2.16
CFO/CapEx	28.6	288.67	263.67	16.92	10.32	11.63	6.86	7.39	21.57	-48.25	10.38	-0.8	-5.66	1.16
Altman's Z-Score	9.81	9.55	8.89	82.14	99.13	107.4	147.48	45.24	18.25	46.91	95.67	110.86	64.46	61.91

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Accounts Receivable Turnover	- -	5.04	5.5	6.74	6.13	5.66	4.73	3.82	3.41	3.49	4.15	4.27	4.61	4.68
Days Sales Outstanding	- -	72.37	66.34	54.18	59.57	64.51	77.14	95.52	107.18	104.65	87.9	85.48	79.14	78.04
Inventory Turnover	- -	2.85	2.97	2.47	2.18	2.4	2.24	1.97	1.85	1.17	1.35	1.44	1.4	1.48
Days Inventory Outstanding	- -	128.14	122.84	147.92	167.45	151.8	163.2	185.35	196.84	312.32	270.16	252.6	261.16	247.28
Accounts Payable Turnover	- -	2.7	2.38	2.41	3.71	3.33	3.15	3.54	3.14	3.97	5.61	5.76	5.42	5.37
Accounts Payable Turnover Days	- -	134.97	153.23	151.48	98.27	109.5	115.85	103.1	116.26	92.03	65.08	63.34	67.38	67.94
Cash Conversion Cycle	- -	65.54	35.94	50.62	128.75	106.81	124.49	177.77	187.76	324.94	292.98	274.74	272.92	257.38
Inventory to Cash Days	- -	-55.77	-56.5	-93.74	-107.87	-87.29	-86.06	-89.83	-89.66	-207.67	-182.25	-167.12	-182.02	-169.24
Inventories	32	34	36	41	48	41	52	78	73	93	95	114	135	178
Raw Materials	6	8	8	7	11	9	14	31	28	38	34	27	38	33
Work In Process	14	11	15	9	21	16	19	24	22	19	28	42	34	51
Finished Goods	12	15	13	25	16	16	19	23	23	36	33	45	63	94
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Market Capitalization	- -	- -	- -	160,291	192,438	262,907	397,494	104,072	37,576	108,888	253,288	311,147	207,018	169,509
- Cash & Cash Equivalents	7	25	7	331	467	692	863	924	1,060	858	1,102	774	316	319
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	736	605	535	482	241	293	285	286	277	283	375
Enterprise Value	-7	-25	-7	160,696	192,576	262,750	397,113	103,389	36,809	108,315	252,472	310,531	206,891	169,564
Total Capital	254	145	1,229	1,572	1,644	1,557	1,586	1,629	1,815	1,669	1,794	1,648	56	-17
Total Debt/Capital (%)	- -	- -	- -	46.82	36.8	34.36	30.39	14.79	16.14	17.08	15.94	16.81	505.36	-2,205.88
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.01	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	144.12	189.92	248.35	363.32	102.87	46.89	167.41	319.18	344.65	189.29	142.73
EV/EBITDA	- -	- -	- -	285.94	556.58	1,763.42	2,057.58	327.18	206.79	- -	1,394.87	1,444.33	851.4	743.7
EV/EBIT	- -	- -	- -	285.94	556.58	1,763.42	2,057.58	327.18	206.79	- -	1,394.87	1,444.33	851.4	743.7
EV/Cash Flow to Firm	- -	- -	- -	364.62	532.57	621.58	1,278.27	312.64	219.92	- -	662.56	32,173.72	- -	3,786.11
EV/Free Cash Flow to Firm	- -	- -	- -	344.31	490.51	574.05	1,122.85	278.15	211.09	- -	608.29	21,194.19	- -	2,237.41
Diluted Market Cap	- -	- -	- -	161,474	196,323	271,433	412,573	107,506	38,816	114,405	268,188	325,930	213,793	169,509
Diluted Enterprise Value	-7	-25	-7	161,879	196,461	271,276	412,192	106,823	38,049	113,832	267,372	325,433	213,760	169,565
EV per Share	- -	- -	- -	1,118.15	1,339.98	1,824.97	2,753.42	710.92	253.1	738.98	1,733.3	2,233.84	1,506.79	1,281.57
TTM Sales	1,254	1,339	1,216	1,115	1,014	1,058	1,093	1,005	785	647	791	901	1,093	1,188
TTM EBITDA	872	884	695	562	346	149	193	316	178	-156	181	215	243	228
TTM Operating Income	872	884	695	562	346	149	193	316	178	-156	181	215	243	228
TTM Cash Flow to Firm	715	866	791	441	362	423	311	331	167	-172	381	10	-270	45
TTM Free Cash Flow to Firm	740	869	794	467	393	458	354	372	174	-168	415	15	-217	76

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Price/Free Cash Flow	- -	- -	- -	346.51	559.32	614.1	1,220.63	312.52	245.67	-605.32	692.99	325,930.4	-865.56	2,529.98
EV/EBIT	- -	- -	- -	285.94	556.58	1,763.42	2,057.58	327.18	206.79	- -	1,394.87	1,444.33	851.4	743.7
Enterprise Value	-7	-25	-7	160,696	192,576	262,750	397,113	103,389	36,809	108,315	252,472	310,531	206,891	169,564
Low Price	- -	- -	- -	892.3	1,010.49	915.77	1,596.11	473.98	137.23	215.86	682.27	1,424.23	1,429.16	724.12
EV/Sales	- -	- -	- -	144.12	189.92	248.35	363.32	102.87	46.89	167.41	319.18	344.65	189.29	142.73
EV/EBITDA	- -	- -	- -	285.94	556.58	1,763.42	2,057.58	327.18	206.79	- -	1,394.87	1,444.33	851.4	743.7
Price/Earnings	- -	- -	- -	397.74	844.02	7,511.62	6,853.34	378.44	280.42	- -	1,235.55	- -	103,278.21	84,754.31
Price/Earnings Average	- -	- -	- -	375.45	965.23	6,522.31	5,476.99	1,141.39	447.11	-515.95	843.87	-5,790.32	-2,147.34	96,087.35
Price/Earnings High	- -	- -	- -	416.34	1,335.4	9,789.85	7,035.11	1,787.11	905	-1,057.58	1,276.74	-7,144.6	-2,651.95	148,769.59
Price/Earnings Low	- -	- -	- -	318.21	636.94	3,767.1	3,968.96	250.66	148.94	-213.78	484.77	-4,499.66	-1,521.18	47,903.53
Price/Book Value	- -	- -	- -	191.74	185.21	257.25	360.05	74.98	24.69	78.68	167.96	226.95	-911.97	-432.42
Price/Book Value Average	- -	- -	- -	180.99	211.81	223.37	287.74	226.14	39.36	55.17	114.72	185.83	-1,220.3	-490.24
Price/Book Value High	- -	- -	- -	200.7	293.04	335.27	369.6	354.07	79.68	113.09	173.56	229.29	-1,507.06	-759.03
Price/Book Value Low	- -	- -	- -	153.39	139.77	129.01	208.51	49.66	13.11	22.86	65.9	144.41	-864.46	-244.41
Price/Tangible Book Value	- -	- -	- -	-283.2	-564.33	-695.52	-1,347.44	-5,781.79	274.28	5,444.38	2,093.29	-16,376.14	-1,009.84	-477.49
Price/Tangible Book Value Average	- -	- -	- -	-267.32	-645.37	-603.92	-1,076.83	-17,437.83	437.32	3,818.03	1,429.7	-13,409.16	-1,351.25	-541.34
Price/Tangible Book Value High	- -	- -	- -	-296.44	-892.88	-906.47	-1,383.17	-27,303.05	885.18	7,826.07	2,163.07	-16,545.39	-1,668.79	-838.14
Price/Tangible Book Value Low	- -	- -	- -	-226.57	-425.87	-348.81	-780.34	-3,829.46	145.67	1,581.94	821.31	-10,420.26	-957.23	-269.88
Price/Sales	- -	- -	- -	143.76	189.78	248.49	363.67	103.55	47.87	168.3	320.21	345.33	189.4	142.68
Price/Sales Average	- -	- -	- -	135.7	217.03	215.77	290.64	312.32	76.32	118.02	218.7	282.77	253.44	161.76
Price/Sales High	- -	- -	- -	150.48	300.27	323.86	373.32	489.01	154.48	241.92	330.89	348.9	312.99	250.45
Price/Sales Low	- -	- -	- -	115.01	143.22	124.62	210.61	68.59	25.42	48.9	125.64	219.74	179.53	80.65
Price/Cash Flow	- -	- -	- -	364.3	601.37	645.96	1,347.44	343.47	248.85	-564.18	717.53	-77,786.65	-690.06	4,708.57
Price/Cash Flow Average	- -	- -	- -	343.88	687.73	560.89	1,076.83	1,035.91	396.77	-395.65	490.07	-63,693.49	-923.36	5,338.19
Price/Cash Flow High	- -	- -	- -	381.33	951.48	841.88	1,383.17	1,621.96	803.11	-810.99	741.45	-78,590.59	-1,140.34	8,264.98
Price/Cash Flow Low	- -	- -	- -	291.45	453.82	323.95	780.34	227.49	132.17	-163.93	281.53	-49,496.24	-654.11	2,661.31
Price/Free Cash Flow Average	- -	- -	- -	327.09	639.65	533.22	975.49	942.55	391.7	-424.5	473.31	266,879.25	-1,158.19	2,868.28
Price/Free Cash Flow High	- -	- -	- -	362.71	884.96	800.35	1,253	1,475.79	792.86	-870.12	716.09	329,298.95	-1,430.36	4,440.88
Price/Free Cash Flow Low	- -	- -	- -	277.22	422.09	307.97	706.9	206.99	130.48	-175.88	271.9	207,391.98	-820.46	1,429.96
EV/Sales Average	- -	- -	- -	136.06	217.17	215.62	290.29	311.64	75.34	117.14	217.67	282.22	253.41	161.81
EV/Sales High	- -	- -	- -	150.84	300.4	323.71	372.97	488.33	153.51	241.03	329.86	348.35	312.96	250.5
EV/Sales Low	- -	- -	- -	115.37	143.35	124.47	210.26	67.91	24.45	48.02	124.61	219.19	179.5	80.69
EV/EBITDA Average	-0.01	-0.03	-0.01	269.95	636.45	1,531.03	1,643.96	991.13	332.28	-485.82	951.26	1,182.68	1,139.81	843.12
EV/EBITDA High	-0.01	-0.03	-0.01	299.27	880.38	2,298.57	2,112.2	1,553.08	676.98	-999.67	1,441.53	1,459.84	1,407.69	1,305.24
EV/EBITDA Low	-0.01	-0.03	-0.01	228.9	420.12	883.84	1,190.77	215.97	107.81	-199.14	544.54	918.55	807.4	420.45
EV/EBIT Average	-0.01	-0.03	-0.01	269.95	636.45	1,531.03	1,643.96	991.13	332.28	-485.82	951.26	1,182.68	1,139.81	843.12
EV/EBIT High	-0.01	-0.03	-0.01	299.27	880.38	2,298.57	2,112.2	1,553.08	676.98	-999.67	1,441.53	1,459.84	1,407.69	1,305.24
EV/EBIT Low	-0.01	-0.03	-0.01	228.9	420.12	883.84	1,190.77	215.97	107.81	-199.14	544.54	918.55	807.4	420.45
Last Price	- -	- -	- -	1,115.33	1,339.02	1,826.06	2,756.06	715.62	258.38	742.89	1,738.9	2,238.27	1,507.71	1,281.16
High Price	- -	- -	- -	1,167.49	2,118.58	2,379.89	2,829.16	3,379.33	833.88	1,067.88	1,796.87	2,261.4	2,491.53	2,248.82
Enterprise Value Average	-7	-25	-7	151,711	220,210	228,124	317,285	313,198	59,145	75,788	172,178	254,277	276,974	192,231
Enterprise Value High	-7	-25	-7	168,191	304,610	342,488	407,655	490,772	120,503	155,948	260,916	313,865	342,069	297,595
Enterprise Value Low	-7	-25	-7	128,642	145,361	131,691	229,819	68,247	19,190	31,066	98,563	197,488	196,199	95,863

Shares Outstanding	144	144	144	144	144	144	144	146	146	147	140	136	137	125
Diluted Weighted Avg Shares	147	147	144	145	147	149	150	150	150	154	154	146	142	132
Basic Weighted Avg Shares	147	147	144	144	144	144	144	145	145	147	146	139	137	132
Revenue per Share	8.51	9.09	8.46	7.76	7.06	7.35	7.58	6.91	5.4	4.41	5.43	6.48	7.96	8.98
EBITDA per Share	5.92	6	4.84	3.91	2.41	1.03	1.34	2.17	1.22	-1.06	1.24	1.55	1.77	1.72
Operating Income per Share	5.92	6	4.84	3.91	2.41	1.03	1.34	2.17	1.22	-1.06	1.24	1.55	1.77	1.72
Basic EPS, GAAP	4.17	4.12	3.4	2.8	1.59	0.24	0.4	1.89	0.92	-1.01	1.41	-0.32	-0.94	0.02
Basic EPS from Cont Ops	4.17	4.12	3.4	2.8	1.59	0.24	0.4	1.89	0.92	-1.01	1.41	-0.32	-0.94	0.02
Diluted EPS, GAAP	4.17	4.12	3.4	2.78	1.56	0.24	0.39	1.83	0.89	-0.96	1.33	-0.3	-0.91	0.02
Diluted EPS from Cont Ops	4.17	4.12	3.4	2.78	1.56	0.24	0.39	1.83	0.89	-0.96	1.33	-0.31	-0.91	0.02
Dividend per Share	- -	- -	1.66	3.48	0.16	0.48	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	4.85	5.88	5.5	3.06	2.23	2.83	2.05	2.08	1.04	-1.32	2.42	-0.03	-2.18	0.27
Free Cash Flow per Basic Share	4.68	5.86	5.48	2.88	2.01	2.58	1.75	1.8	0.99	-1.34	2.19	-0.06	-2.57	0.04
Cash & Equivalents per Share	0.05	0.17	0.05	2.3	3.25	4.81	5.98	6.35	7.29	5.85	7.57	6.42	2.99	2.42
Book Value per Share	1.72	0.98	8.55	5.82	7.23	7.1	7.65	9.54	10.47	9.44	10.35	9.86	-1.65	-2.96
Tangible Book Value per Share	0.81	0.19	-1.11	-3.94	-2.37	-2.63	-2.05	-0.12	0.94	0.14	0.83	-0.14	-1.49	-2.68

Indivior Pharmaceuticals Inc

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)